People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...

Low-risk patients with severe, symptomatic aortic stenosis show similar clinical outcomes and valve durability ...

PARTNER 3 may notch a win for transcatheter aortic valve replacement in patients with low surgical risk, according to experts ...

People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort ...

Seven-year follow-up data show that transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement have ...

People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort from the American Heart Association designed to boost clinical trial ...

PARADIGM: A Prospective rAndomized tRial Assessing the safety and effectiveness of the DurAVR® bIomimetic valve designed for physioloGic flow compared to CoMmercial TAVR devices MINNEAPOLIS and ...

A 41-year-old Singaporean woman has given birth to a healthy baby girl after undergoing a rare, high-risk fetal heart surgery ...

Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.

Anteris Technologies has won FDA approval to conduct a key clinical trial for its heart valve device in the US.

The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in ...

Anteris Technologies ( ($AU:AVR) ) has issued an announcement. Anteris Technologies has received FDA approval to begin the PARADIGM Trial, a ...